Anthias Biopharma Private Limited
Manufactures and trades pharmaceutical products, incorporated in 2018, based in Mumbai.
2018 | Mumbai, Maharashtra (India) | Active
Anthias Biopharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 713.22%
- Profit Growth -101.85%
- Ebitda -134.29%
- Net Worth -218.28%
- Total Assets -5.92%
About Anthias Biopharma
Anthias Biopharma Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2018 (Six years and five months 17 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shalini Agarwal and Shreyasi Agrawal serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999MH2018PTC317397
- Company No.
317397
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Anthias Biopharma Private Limited
Explore comprehensive data for Anthias Biopharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Anthias Biopharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalini Agarwal  | Director | 26-Nov-2018 | Current |
| Shreyasi Agrawal | Director | 26-Nov-2018 | Current |
Financial Performance of Anthias Biopharma.
Anthias Biopharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 713.22% increase. The company also saw a substantial fall in profitability, with a 101.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 218.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anthias Biopharma?
In 2021, Anthias Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aaja Residency Private LimitedShalini Agarwal and Shreyasi Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anthias Biopharma?
Unlock and access historical data on people associated with Anthias Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anthias Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anthias Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Anthias Biopharma
Recent activity within the organization
- Annual General Meeting
Anthias Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Anthias Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Shalini Vinod Agarwal was appointed as a Director was appointed as a Director on 26 Nov 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Shreyasi Agrawal was appointed as a Director was appointed as a Director on 26 Nov 2018 & has been associated with this company since 6 years 5 months .
- Company Incorporation
Anthias Biopharma Private Limited was registered on 26 Nov 2018 with Roc Mumbai & aged 6 years 5 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Anthias Biopharma Private Limited?
Anthias Biopharma Private Limited was incorporated on 26 Nov 2018.
What is authorized share capital and paid-up capital of Anthias Biopharma Private Limited?
The authorized share capital of Anthias Biopharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Anthias Biopharma Private Limited?
Currently 2 directors are associated with Anthias Biopharma Private Limited.
- Shalini Vinod Agarwal
- Shreyasi Agrawal
What is the registered address of Anthias Biopharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Anthias Biopharma Private Limited is Flat No. 405 P S Centre Daftary Road Malad E, Opp. Railway Station India, Mumbai, Maharashtra, 400064.
What is the corporate identification number (CIN) and company number of Anthias Biopharma Private Limited?
The corporate identification number (CIN) of Anthias Biopharma Private Limited is U74999MH2018PTC317397 and the company number is 317397 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Anthias Biopharma Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Anthias Biopharma Private Limited has risen by 713.22%.
What change has been observed in the net worth of Anthias Biopharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Anthias Biopharma Private Limited has experienced an downturn of -218.28%.
When was the last Balance Sheet of Anthias Biopharma Private Limited filed with the ROC?
The most recent Balance Sheet for Anthias Biopharma Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records